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Excretionof Digoxin-likeImmunoreactivityin Urine of Normal Subjects:Correlationswith
Excretion of Creatinine and Electrolytes
Aide Clerico, Ottavlo Glampletro,Glovanna Gregorl, Maria Grazia Del Chicca, Stetanla Bertoll, Roberto Miccell,and Renzo Navaleal
To verify whether there is a variation in the 24-h urinary
excretion of digoxin-like immunoreactivity (DLIs) in humans,
we studied 18 normal adults, who collected their urines for
24-h in several portions. We then measured DLIS (by means
of a sensitive RIA method), creatinine, sodium, and potassi-
um concentrations in the urine samples. The mean urinary
excretion rate for DLIS in the complete 24-h collectionwas
84.8 (SD 31.3) pg/mm. The mean DLIS urinary excretion rate
calculated for overnight collectionswas significantly lower
than those of afternoon collections (P <0.01) and the 24-h
collection (P <0.05). Significant positive correlations were
found between urinary DLIS and excretion rates for creatinine
(r= 0.347, P= 0.0016),Na (r= 0.232, P= 0.038), and K
(r = 0.323, P = 0.003), respectively. Our data suggest that
urinary excretion of DLIS is higher during “active” hours of the
day, especially in the afternoon, than at rest, during the night.
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Several studies have documented the presence of an
endogenous factor with digoxin-like immunoreactivity
(Dus) in blood of experimental animals and humans, as
determined with digoxin RIA or enzyme immunoassay
methods for digoxin (for a review, see references 1-5).
Experimental studies and theoretical considerations sug-
gest that DUS might also be an endogenous modulator for
NaVK-ATPase (the receptor of cardiac glycosides) and
could play a role in the regulation of fluids and electrolytes,
and in the pathogenesis of hypertension (1, 3, 4).
BUS concentrations in plasma or serum of normal adult
subjectsare frequently closeto the limit of sensitivity of RIA
methods (6-8). Therefore, such samples are generally con-
centrated to improve the precision of the assay in studies of
normal adult subjects. On the other hand, because DLIS
concentrations in urine samples of adults and newborns are
four- to sixfold greater than in plasma samples, direct RIA
could be preferable for urine samples (8). However, studies
on the variationin 24-h urinary excretion of DLIS in normal
subjects have not been reported.
Here we report the urinary excretion rate of BUS in 18
normal subjects, as measured by a sensitive RIA method in
which digoxin added to a buffer solution containing serum
albumin serves as the standard. In addition, we investigated
whether there are variations of urinary BUS excretion
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throughout the day and if the urinary DUS values in normal
adult subjects are correlated with urinary creatinmne and
electrolytes, as previously reported for newborns and boys
(9, 10).
Materials and Methods
DLIS assay. We measured DLIS by a previously reported
solid-phase RIA method (7, 8). In this method, digoxin
dissolved in a buffercontaining 40 of human serum
albumin per liter is used as standard, 1 I-labeled digoxin is
the tracer, and a solid phase (antibody coated test-tubes) is
used for separating bound digoxin from free. To improve the
sensitivity and the reproducibility of the assay as well as the
stability of standard curves, we used an assay buffercon-
taining human serum albumin, 40 g/L. The same albumin-
containing bufferwas added to unknown urine samples to
equalizethe influenceof albumin in the reaction volume (8).
Results are expressed as digoxin equivalents.
We directly assayed 0.2-mL samples of urine. The mean
sensitivity obtained in 20 separate experiments, performed
during nine months, was 2.98 (SD 1.11) pg per tube. The
mean intra-assay CV (precision profile) ranged between 4%
and 20% (range of the assay: 50-500 ng/L), as previously
reported (8). In addition, the mean between-assay CVs,
tested during 10 months (n = 25) with two different urine
pools, were 12.9% (digoxin equivalent, mean ± SD, 281.9
±36.4 ngIL) and 19.5% (120.0 ±23.4 ng/L), respectively. In
addition, assaying increasing volumes of one urine pool gave
a linear response (from 25 to 250 ng/L), as previously
reported (8). The mean DLIS concentration in 62 plasma
samples from normal subjects was 15.7 (SD 8.8) ng/L (range
0-32 ngIL).
The antiserum we used cross reacts with digitoxin by
35%, but negligibly (<0.1%) with testosterone, progester-
one, cortisone, aldosterone, estradiol, estriol, cholesterol,
dehydroepiandrosterone, cortisol, prednisone, prednisolone,
spironolactone, or ouabain, as previously reported (7).
Creatinine and electrolyte assays. Creatinine was mea-
sured colorimetrically with creatinine reagent kit PIN
668306 (Astra System, Beckman Instruments, Inc., Galway,
Ireland). Urinary sodium and potassium concentrations
were measured with a Model 435 flame photometer (Cor-
ning Medical, Haisted, Essex, U.K.).
Subjects. We studied 18 normal, healthy subjects (10
women and eight men, ages 22-54 years, mean 29.1, SD 6.7
years), who collected their urines for 24 h, in several
portions. The first urine sample on the morning of the day of
the 24-h collection (sample 0) was put in a separate contain-
er. Subsequently, the complete 24-h urinary collec-
tion consisted of: sample 1, from waking to lunch; sample 2,
from lunch to dinner; sample 3, from dinner to bedtime;
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rig. 1. Mean (±SEM) unnary excretionrate of DUS in the different
portions of 24-h urinecollected fromthe 18 subjects (see Table 1)
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Table 1. DLIS/CR RatIos for the Different Specimens of
Urine from 18 Normal Persons
SpecImen Mean
DLIS(nq/L)/CR(q/L)ratio
0. Firstmorning 64.88 15.7
1. Morning 83.6 28.7
2. Afternoon 92.5 44.1
3. Evening 75.9 30.6
4. Overnight 68.28 23.7
5. 24 h (1-4) 83.1 29.7
8Significantly different (P <0.01, unpaired f-test) from 24-h collection
(sample5).
sample 4, overnight, at rest. The volume of each portion was
recorded, as was the time of collection. From each fraction
we took three 1-mL aliquots, for assay of DUS, creatinine,
and electrolytes. We then pooled urine fractions 1 to 4, to
yieldthe complete 24-h collection (sample 5). All samples
were stored at -20 #{176}Cuntil assay. To minimize analytical
error, we used the same lot of standard solutions, coated-
tubes, and tracer solution in assaying the urine samples.
BUS and creatinine concentrations were measured in each
portion of urine (n = 108); electrolytes were measured in the
samples of 16 of the 18 subjects (n = 96). Finally, we
calculated the urinary excretion rates of DLIS (pg/mm),
creatinine (mg/mm), and electrolytes (mmollmin) on frac-
tions 1 to 4 (n = 90), but not on sample 0, which was not
timed.
Statistical analysis. We calculated all sample values, the
index of sensitivity, the precision proffle, and the data for
quality control of the RIA systems by means of previously
described computer programs (11, 12). The interpolation of
the dose-response curves was calculated by using a four-
parameter logistic function (12).
For statistical analysis for comparison of mean values,
and calculation of simple and multiple regression coeffi-
cients, we used a Macintosh SE personal computer and the
512k Stat-View1M program.
Results
Concentrations of BUS in all the urine samples ranged
between 22.5 and 231.5 ng/L (mean ± SD = 114.1 ± 43.8
ng/L, n = 108). The mean BLIS excretion rate for our
subjects, calculated on the complete 24-h collection, was 84.8(SD31.3)pg/mm, correspondingto a daily urinary excretion
of 122 (SD 45) ng/24 h. The mean BUS urinary excretion
rates, in samples 1 to 5, differed significantly from portion to
portion (P <0.05, ovA) (Figure 1). The value for the
overnight collection (sample 4) was significantly lower than
values for samples 2 (afternoon collection, P <0.01) and 5
(24-h collection, P <0.05).
We found a significant positive correlation between uri-
nary DUS and creatinine concentrations (Bus = 107 + 0.33
creatinine, r = 0.601, n = 108, P <0.001). Table 1 lists the
means of each BLIS/creatmine concentration ratio (Bus/CR)
obtained for the six different portions of 24-h urine (samples
0 to 5). Differences among the mean ratios in the six
fractions were significant (P <0.001, AN0VA). Moreover, the
BUS/CR ratios found in urine fractions 0 to 4 correlated
positively with the value of the complete 24-h collection
(fraction 5), with r ranging between 0.63 and 0.84 (n 18, P
<0.001).
Weak positive correlations were found between the rates
of urinary excretion of DLIS and of creatinine (Bus = 72.7 +
13.3 creatinine,n = 80, r = 0.347, P = 0.002), Na (Bus =
72.5 + 4.5 Nap, r =0.232, n = 80,P <0.038), and K (Dus =
72.6 + 146.0 K, r = 0.323, n = 80, P = 0.004). Stepwise
multiple-regression analysis among K, Na, and creati-
nine excretion rates and that of BLIS showed that only K
values significantly (P <0.02) improved the regression
between BLIS and creatinine excretion rates: BUS = 32.3 +
355.7 K + 29.1 creatinine (n = 80, r = 0.435, P <0.001).
Discussion
This study confirms that urine from healthy adult sub-
jects contains higher BUS concentrations than do the corre-
sponding plasma samples. The greater amounts of BUS in
urine samples permit a better precision of assay. In addition,
because the BLIS/CR ratio for an untimed morning urinary
sample (sample 0 of this study) correlates positively (r =
0.819, P <0.001) with the ratio for the complete 24-h
collection, one can simply collect the first morning urine and
validly use it to estimate the daily excretion of BUS. Howev-
er, a complete 24-h collection is necessary for accurate
determination of the mean urinary excretion of BUS during
the day.
Here, we measured DUS values with a very sensitive RIA
method specifically developed in our laboratory for assay of
digoxin-like immunoreactivity (6-8). As previously reported
for plasma extracts from adults, pregnant women, and
newborns, the results obtained with this RIA method corre-
late well with those obtained with a radioreceptor assay
involving the binding of E3Hlouabain to erythrocytes (13).
This correlationmight suggestthat our RIA detects, to some
extent, substances with immunological and biological activ-
ity similar to cardioactive glycosides.
Our data indicate that urinary excretion of an endogenous
factor (or a group of substances) with digoxin-like immuno-
reactivity is higher during the “active” hours of the day,
especially in the afternoon, than at rest during the night.
Strenuous physicalactivity(14), infusion of saline solution
(15), and high-sodium diet (16) have been previously report-
ed to increase concentrations of BUS plasma or urine of
normal subjects and hypertensive patients. Significant posi-
tive correlations between urinary BUS and creatinine con-
centrations (and excretion rates) have been found in our
study, as previously reported for samples from newborns
and boys (9, 10). Together, these findings suggest that the
urinary excretion of BUS is to some extent dependent on
glomerular filtration rate, which in turn accords with the
hypothesis that BUS is an ultrafiltrable substance with a low
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molecular mass (1,3,5,17). The increase in the glomerular
filtration rate and diuresis may explain a greater urinary
excretion of DU5 during the day as compared with at rest, as
also previously suggested by otherauthors(18) who report-
ed a correlation between the presence of digoxin-like im-
munoactivity in urine and induced diuresis in normal
individuals.
We also found weak, but significant, positive correlations
between urinary BUS excretion rate and the respective rates
for K and Nat. These data accord well with the findings of
Gault et al. (15), who reported that plasma BUS correlated
positively with urinary sodium excretion in 12 hypertensive
patients before and after infusion of saline solution, and of
Ebara et al. (19), who found a positivecorrelationbetween
serum BUS values and the fractional excretion of Na in 53
pairedsamples of infants. However, in the present study,
using a stepwise multiple-regression analysis, only urinary
K, not Na values, significantly improved the regression
between urinary BUS and creatinine excretion rates in
normal adults. Further studies are needed to elucidate the
relationships between urinary DUS and electrolyte excre-
tions.
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